I am not sure you are using the correct figures in reaching your assessment. This is from last weeks 10k (Appendix F Page 3)
Although revenue declined by about 15% Gross Profit was up very significantly. So service was profitable and substantially more so than 2022.
Lab Testing Gross Profit -
2023 A$ 608k
2022 A$ 146K
They also note that 69% of the revenue was accounted for in 2H 2023. So on a run rate basis this would show a higher revenue number than FY 2022.
The HRL Testing in Canada, page-2
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 215127 | 7 |
View Market Depth
| Last trade - 10.09am 03/10/2024 (20 minute delay) ? |
| UBI (ASX) Chart |
Day chart unavailable